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Available online 9 February 2016Monoglyceride lipases (MGLs) are a group of α/β-hydrolases that catalyze the hydrolysis of monoglycerides
(MGs) into free fatty acids and glycerol. This reaction serves different physiological functions, namely in the
last step of phospholipid and triglyceride degradation, inmammalian endocannabinoid and arachidonic acidme-
tabolism, and in detoxiﬁcation processes inmicrobes. Previous crystal structures of MGLs from humans and bac-
teria revealed conformational plasticity in the cap region of this protein and gave insight into substrate binding. In
this study, we present the structure of a MGL from Saccharomyces cerevisiae called Yju3p in its free form and in
complex with a covalently bound substrate analog mimicking the tetrahedral intermediate of MG hydrolysis.
These structures reveal a high conservation of the overall shape of theMGL cap region and also provide evidence
for conformational changes in the cap of Yju3p. The complex structure reveals that, despite the high structural
similarity, Yju3p seems to have an additional opening to the substrate binding pocket at a different position com-
pared to human and bacterial MGL. Substrate speciﬁcities towards MGs with saturated and unsaturated alkyl
chains of different lengths were tested and revealed highest activity towards MG containing a C18:1 fatty acid.
© 2016 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).Keywords:
Monoglyceride lipase
Monoacylglycerol lipase
Crystal structure
Lipase–substrate-complex
Lipase cap
Substrate speciﬁcity1. Introduction
Lipases are hydrolases that cleave ester bonds in lipids and therefore
act at a water–lipid interface. Many lipases contain a variable lid or cap
region which covers the active site and forms the substrate binding
pocket in combination with an α/β-hydrolase core domain. In some li-
pases, this cap region is considered to play a role in interfacial activation
[1,2]. Monoglyceride lipases (MGLs) are a subclass of lipases and cata-
lyze the breakdown of monoglycerides (MGs) resulting in free fatty
acids and glycerol molecules. MGLs are predominantly speciﬁc towards
MGs, yet are not reported to be regiospeciﬁc or stereospeciﬁc (1-, 2- or
3-MGs) [3–9]. MGLs are conserved across all species and serve different
biological roles in different species and tissues. In mammals, MGLs play
an essential role in energy homeostasis, where they catalyze the last
step of phospholipid and triglyceride breakdown [10]. Furthermore,
they play a role in lipid signaling by regulating the levels of the. This is an open access article underendocannabinoid 2-arachidonoyl-glycerol (2-AG), the most abundant
endogenous agonist of cannabinoid receptors [11–13]. By hydrolyzing
2-AG, MGL also determines the availability of arachidonic acid for
prostaglandin synthesis in the brain [14]. In microbes, MGs have been
shown to be toxic renderingMGL important for detoxiﬁcation processes
[15–17]. Pathogenic bacteria, includingMycobacterium tuberculosis, ac-
cumulate lipids in the dormant phase. Enzymes involved in degradation
of these lipid depots may be essential in providing energy and precur-
sors for cell wall synthesis during the reactivation step and the chronic
phase [18]. Due to these different biological roles, MGLs are interesting
subjects for drug targeting [14,18–20].
Despite the fact that MGLs have been studied for decades, very little
three-dimensional (3D) structural data is available. The only experi-
mentally determined 3D structures are those of human MGL (hMGL)
and MGL from Bacillus sp. H-257 (bMGL) [12,21–25]. hMGL was deter-
mined in its free form and in complex with inhibitors, bMGL in its
free form and in complex with inhibitors and the natural substrate.
The structures of the two enzymes are very similar despite the large
evolutionary distance between bacteria and humans. Apart from thethe CC BY license (http://creativecommons.org/licenses/by/4.0/).
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markable, namely the similarity of the overall shape of the cap regions
and its conformationalﬂexibility [22,23]. Based on the conservedoverall
shape of the cap region in hMGL and bMGL, we hypothesized that this
general cap architecture might also be present in other species. In
order to test this, we herein focus on Yju3p, theMGL ortholog from Sac-
charomyces cerevisiae [26,27]. Low sequence identity to bMGL and
hMGL precludes reliable homology modeling without introducing a
heavy model bias, rendering an experimentally determined structure
a key requirement. A solubility enhancing mutation was introduced
into the coding sequence of Yju3p (hereafter named s-Yju3p) which
allowed concentrations of the puriﬁed protein in themg/ml rangewith-
out the addition of detergents. Furthermore, we investigated whether
the modes of substrate binding are comparable to MGLs with known
structures by analyzing complex structures mimicking the tetrahedral
reaction intermediate. Thus, we present crystal structures of s-Yju3p
in its free form and in complexwith an inhibitormimicking the tetrahe-
dral intermediate of a C20:0 MG during hydrolysis. s-Yju3p harbors an
α/β-hydrolase core and a cap region similar to those of hMGL and
bMGL. Interestingly, the structure of the inhibitor complex revealed dif-
ferences in the mode of substrate binding in s-Yju3p compared to the
other two MGLs. Analysis of the MG hydrolase activity of s-Yju3p un-
veiled differences in substrate preferenceswith respect to the saturationFig. 1. Structures of s-Yju3p in free formand in complexwith a substrate analogmimicking a C20
s-Yju3p with theα/β-hydrolase core colored in dark orange and the cap region in yellow (PDB
the catalytic triad is highlighted with a black rectangle. This orientation of the molecule is term
result of a rotation of 75° around the x axis and−90° around the z axis from this standard o
and of −90° around the y axis from the standard orientation. C, cartoon of the isolated cap
E, substrate analog with a C18:0 carbon chain mimicking a C20:0 MG substrate [48]. The red ov
ophilic serine and is not present anymore in the complex structure. F, C20:0MG analog (blue sti
ture of the s-Yju3p substrate analog complex (cutoff = 1 sigma) (PDB code 4ZXF), bottom: 2Fo
was omitted (cutoff = 1 sigma) as purplemesh and positive density in corresponding Fo-Fcma
the C20:0 MG analog (blue sticks) (α/β-hydrolase core in green, cap in orange, PDB code 4ZW
carbon chain of the substrate analog shown as sticks, green: s-Yju3p α/β-hydrolase core, oran
analog complex embracing the substrate; the C20:0 substrate analog is shown as gray stick
blue= positive, red = negative). The position of Ile166 is indicated by an arrow and the positi
chain of the C20:0MG analog chain leaves the enzyme is indicated by a black rectangle. In this o
image was created using UCSF chimera [46].state of the MG substrate. These data can be rationalized by differences
in the shapes of the active site cavities in the three MGLs.
2. Experimental methods
2.1. Synthesis of substrate analogs
p-Nitrophenyl esters of alkyl phosphonic acids were used to mimic
the natural MG substrate and employed for co-crystallization studies.
The C20:0 MG mimicking substrate analog was synthesized as de-
scribed previously [22]. The identity of the compound was conﬁrmed
using mass spectrometry and NMR spectroscopy. As outlined before,
the substrate analog contained a carbon chain consisting of only 18 car-
bons, yet it mimics a C20:0 substrate. This can be rationalized by its
chemical structure which has a phosphor-atom at the position where
the carbon of the carbonyl group would be placed and an oxygen-
atom is at the position of the ﬁrst methylene group of the carbon
chain (Fig. 1E).
2.2. Cloning and mutagenesis of s-Yju3p
A solubility variant Leu175Ser was produced by applying
QuikChange™ (Agilent Technologies) site directed mutagenesis to the:0MG. A,MGhydrolase activity assay forWT-Yju3pand s-Yju3p. B, overall structure of free
code 4ZWN). Surface mutations Leu175Ser and Gln264Arg are marked with black arrows;
ed “standard orientation” throughout the manuscript. The “top-view” orientation is the
rientation. The “side-view” orientation is the result of a rotation of 45° around the x axis
region of s-Yju3p in the top-view orientation. D, close-up view of the catalytic triad.
al indicates the p-nitrophenol leaving group that is cleaved off upon binding to the nucle-
cks) with the observed electron density; top: 2Fo-Fcmap as bluemesh in the crystal struc-
-Fc map calculated from the s-Yju3p substrate analog complex were the substrate analog
p in green (cutoff=3 sigma). G, close up view of the active site of s-Yju3p in complexwith
N). H, s-Yju3p bound to the C20:0 substrate analog with the side chains surrounding the
ge: s-Yju3p cap region, blue: C20:0 substrate analog. I, opening of the s-Yju3p C20:0 MG
s; the protein is represented as surface (the colors indicate the electrostatic potential,
on of the opening by a black rectangle. The position of the hole through which the carbon
rientation,Met159 is positioned above the paper plane and not visible due to clipping. The
464 P. Aschauer et al. / Biochimica et Biophysica Acta 1861 (2016) 462–470yju3p gene according to themanufactures instructions using the follow-
ing primers: forward primer: 5′-GGC GAA ATT TTC ACC AAG GGT AAG
GAT CGA CAC TGG-3′; reverse: 5′-CCA GTG TCG ATC CTT ACC CTT GGT
GAA AAT TTC GCC-3′. It should be noted here, that the variant used
here also differs at amino acid position 264 (Gln264Arg) compared to
the canonical sequence in data base entry UniProt-ID P28321. We
proceeded with crystallization because i) this variant was described
previously as active in hydrolyzingMGs [26], ii) the amino acid position
is not conserved when comparing the sequence with hMGL or mouse
MGL and, iii) the amino acid is placed in a surface exposed position of
the core domain and thus is very unlikely to interfere with the fold of
the protein. The resulting variant is called s-Yju3p throughout the re-
mainder of the text.
2.3. Expression and puriﬁcation
s-Yju3pwas expressed and puriﬁed as described previously [27]. Ex-
pression and afﬁnity chromatography puriﬁcation for hMGL and Yju3p
were done using the same protocol and buffers as for s-Yju3p with the
exception that the lysis buffer contained 0.5% IGEPAL CA-630 and the
wash and elution buffers 0.05% IGEPAL CA-630, respectively. bMGL
was puriﬁed as described previously [22]. To compare the activities of
the lipases, a buffer containing 0.05% IGEPAL was used for all proteins.
2.4. Monoglyceride hydrolase activity assay
Since MGLs are not regioselective (Fig. 1A) and the 1(3)-racemic
monoglyceride (1(3)-rac MG) substrates are commercially available
with different chain lengths and saturations, we used 1 (3)-rac MGs as
substrates. The monoglyceride hydrolase activity assays for Yju3p, s-
Yju3p, bMGL and hMGL [23] were done as previously described [26]
with the exception that bovine serum albumin was exchanged for 3-
[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonate (CHAPS)
with a ﬁnal concentration of 5 mM and that substrate concentrations
were 2mM. The substrates used were all 1 (3)-racMGs with the excep-
tions of 3-palmitoyl-sn-glycerol (which was not available as racemic
mixture from the same commercial supplier) for the assays displayed
in Fig. 5 and 2-oleoyl-glycerol for assays shown in Fig. 1A.
2.5. Crystallization and data collection: s-Yju3p in free form and in complex
with a MG C20:0 analog
Crystals of s-Yju3p in its free formwere obtained from a protein solu-
tion at 14mg/mL and a reservoir solution containing 0.1MBicine/Trizma
base pH 8.7, 10% w/v PEG 20 000, 20% v/v PEG MME 550 and 0.03 M
sodium nitrate, 0.03 M disodium hydrogen phosphate, and 0.03 M am-
monium sulfate using microseeding [28] as described [27]. Diffraction
data to a resolution of 2.4 Å were collected at the SLS (PSI, Villigen,
Switzerland). Unfortunately, attempts to solve the structurewithmolec-
ular replacement (using the program Phaser (29)) failed. Therefore
structure determination was pursued with heavy atom methods.
In order to obtain a co-crystal structure of s-Yju3p bound to a C20:0
MG mimicking substrate analog, 50 μl protein solution (14.9 mg/ml)
weremixedwith 1 μl C20:0 solution (50mg/ml in ethanol) and incubat-
ed for 1 h at 4 °C. Excess C20:0 mimicking substrate analog and the
resulting nitrophenol were thenwashed off by diluting the complex so-
lution to 500 μl with dialysis buffer and re-concentrating it to 50 μl
twice. This solution was then set up for crystallization using the same
method and condition as for untreated s-Yju3p. Diffraction data were
measured from a crystal resulting from these setups to a resolution of
2.5 Å at ID-29 at the ESRF (Grenoble, France).
2.6. Heavy metal soaking and MAD data collection
s-Yju3p crystals were harvested and transferred to an extra drop
consisting of 1.5 μl of a 10 mM K2Pt(NO2)4 solution and 2.5 μl of thereservoir solution. The crystals were soaked for 6 days and then ﬂash
cooled and stored at liquid nitrogen temperatures. No back soaking of
the crystals was performed. The crystals were taken to ID-23 at the
ESRF (Grenoble, France). After an X-ray ﬂuorescence scan, diffraction
data were collected using three different wavelengths around the plat-
inum absorption edge: 1.07155 Å (peak), 1.07182 Å (inﬂection) and
1.06878 Å (remote).
2.7. Data processing and structure reﬁnement: s-Yju3p
The three data sets collected for crystals soaked with K2Pt(NO2)4
were indexed and integrated using XDS [30] and scaled using Scala
[31]. These data sets were then uploaded to the Auto-Rickshaw server
[32]. A native data set without heavy atom derivatives with a resolution
of 2.5 Å measured at SLS (Villigen, Switzerland) was indexed and inte-
grated using XDS [30], scaling and data reduction were performed
using Aimless [33]. The resolution was cut to achieve reasonable CC1/2
values. The Rmerge in the higher resolution shell was 140% which could
be considered as very high but this was accepted since the CC1/2 value
was still 49%. The biggest fragment with the best electron density ﬁt
from the initial model produced by Auto-Rickshawwas used for molec-
ular replacement in the native data set using PHASER [29]. The best MR
solutionwas used to complete the structurewith phenix.autobuild [34].
Structure reﬁnement was carried out by alternating manual steps in
Coot [35] and automated real-space, ADP, atomic xyz coordinate and oc-
cupancy reﬁnement in phenix.reﬁne. Rfree values were calculated from
5% of the reﬂections separated from the data set. Waters were added
using the “update water” option in phenix.reﬁne and questionable wa-
ters were identiﬁed via weak 2Fo-Fc map intensities and high B-factors
and were manually deleted in Coot. The geometry of the structure was
validated usingMolProbity [36]. The structure could be reﬁned to resid-
ual factors of 22.4% (Rfree) and 18.8% (Rwork). Amore complete list of the
statistics of data processing and reﬁnement is shown in Table 1.
2.8. Data processing and structure reﬁnement: s-Yju3p substrate analog
complex
Diffraction data from a crystal of the s-Yju3p C20:0 MG analog
complex were indexed and integrated using iMosﬂm [37] and scaled
using Scala [31]. 5% of the reﬂections were held back after data reduc-
tion in order to calculate Rfree values for evaluation of the reﬁnement
quality. The resolution was cut at 2.5 Å in order to achieve acceptable
Rmerge values. The reﬁnement was carried out using Coot [35] and
phenix.reﬁne [34]. The processing and reﬁnement statistics are shown
in Table 1. The model for the C20:0 MG analog was generated using
MAESTRO (Maestro, version 9.3, Schrödinger, LLC, New York). A cif
library containing the restraints for this model was prepared using
phenix.elbow [38]. Placement of the ligand was done manually in
Coot. The geometry around the phosphor atom was restrained to tetra-
hedral angles and the distance to the gamma oxygen of Ser123 was re-
strained to amaximumof 1.9 Å. The occupancy of the ligandwas reﬁned
to 0.8. Waters were added to the structure using the “update waters”
option in phenix.reﬁne. Questionable waters were evaluated based on
the 2Fo-Fc map and B-factors and were deleted manually in Coot. The
geometry of the structure was evaluated using MolProbity [36]. The
structure could be reﬁned to an Rfree of 25.68%. 0.33% Ramachandran
outlier remained. The average B-factors for the ﬁnal structure
were 44.8 ± 14.3 and 41.9 ± 8.5 for the protein and the ligand atoms,
respectively. The atomic coordinates and structure factors (codes
4ZWN and 4ZXF) have been deposited in the Protein Data Bank
(http://wwpdb.org/).
2.9. Molecular dynamics simulation
pKa values and protonation states of the titratable amino acids at
pH 7 were calculated using TITRA employing the Tanford–Kirkwood
Table 1
Processing and reﬁnement statistics of s-Yju3p structures.
s-Yju3p free SLS s-Yju3p C20:0 analog complex ID-29 ESRF
Data collection
Wavelength 0.999900 Å 0.97939 Å
Resolution 45.27 Å–2.49 Å (2.57 Å–2.49 Å) 82.72 Å–2.5 Å (2.64 Å–2.5 Å)
Space group P212121 P212121
Unit cell a b c a b c
77.19 Å 108.55 Å 167.64 Å 76.76 Å 107.1 Å 165.5 Å
Total no. of reﬂections 439,569 215,498
Unique reﬂections 49,134 47,793
Rmerge 0.059 (1.410) 0.052 (0.965)
Rpim 0.022 (0.536) 0.024 (0.455)
Rmeas 0.065 (1.597) 0.052 (0.965)
CC 1/2 0.996 (0.49) 0.997 (0.178)
Completeness 94.6% (91.6%) 99.2% (99.6%)
Mean I/sd(I) 30.8 (1.7) 18.3 (1.8)
Multiplicity 8.0 (8.5) 4.2 (4.2)
Average mosaicity 0.1 0.58
Reﬁnement
Rfree 22.40% 25.68%
Rwork 18.83% 20.13%
None solvent atoms 9924 9807
Solvent atoms 408 151
Model geometry
r.m.s.d. bonds 0.005 Å 0.004 Å
r.m.s.d. angles 0.771° 0.806 °
Ramachandran distribution
Ramachandran favored 96.1% 96.91%
Ramachandran disallowed 0.16% 0.33%
Rotamer outlier
Rotamer outlier 0.75% 0.95%
To calculateRfree, 5% of the reﬂectionswere excluded from the reﬁnement.Rmerge is deﬁned asRmerge=ΣhklΣi|Ihkl,j− 〈Ihkl〉| /ΣhklΣjIhkl,j. Rmeas is deﬁned as Rmeas=Σhkl(n/n−1)1/2Σnj = 1|Ihkl,j−
〈Ihkl〉| /ΣhklΣjIhkl,j. Rpim is deﬁned as RpimΣhkl(1/n− 1)1/2Σnj = 1|Ihkl,j− 〈Ihkl〉| /ΣhklΣjIhkl,j. Data in parentheses correspond to the highest resolution shell. r.m.s.d., rootmean square deviation. The
CC 1/2 is the Pearson correlation coefﬁcient between average intensities of two half data sets [49].
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to perform single precision molecular dynamics simulations and equili-
brations [40]. The structure was solvated with water inside a cubic box,
minimized and stepwise (free water, free hydrogens, free side chains,
free protein) equilibrated for 1 ns (NPT and NVT, respectively) followed
by four unrestrained simulations of 100 ns with explicit solvent
employing the OPLS all-atom force ﬁeld and the SPC water model [41,
42]. The backbone RMSD was monitored to ensure complete equilibra-
tion of the protein model. All simulations were carried out with a 2-fs
time step and long-range electrostatic interactions were computed
using the particle mesh Ewald (PME) method. All bonds in the system
were constrained using the LINCS algorithm. The neighbor list search
was updated every 5 steps within a 1.0 nm cut-off. Van der Waals
interactions were computed with a cut-off of 1.4 nm. The isotropic
Parrinello–Rahman protocol was used for pressure (1 bar), and the
velocity-rescaling thermostat was used for temperature coupling. The
components of the system were coupled at 300 K with a coupling
constant of 0.1 ps. Periodic boundary conditions were applied in all
three dimensions. Calculations were performed on 64-bit Linux 64-
core nodes of an AMD Istanbul cluster. Data analysis and image render-
ingwere carried outwith standard tools providedwithin GROMACS and
VMD, respectively [40,43].
3. Results and discussion
3.1. Engineering of s-Yju3p, a solubility enhanced variant of Yju3p
Previous reports identiﬁed Yju3p as a membrane-bound or lipid
droplet associated protein [44]. Accordingly, puriﬁcation and concen-
tration of recombinant Yju3p required the presence of detergents in
order to prevent aggregation (e.g. NP-40, Mega8) [26]. Therefore, we
used a solubility enhancement strategy as described for hMGL to identi-
fy potential hydrophobic residues in the cap region which might be in-
volved in aggregation [24]. Employing this strategy, hMGL carrying thevariations Leu169Ser, Leu176Ser, and Lys36Ala had yielded crystals
diffracting to 1.35 Å. Based on a sequence alignment, we assumed that
amino acid Leu175 of Yju3p corresponds to Leu169 in hMGL. Indeed,
introducing a Leu175Ser mutation proved successful and allowed puri-
ﬁcation, concentration and crystallization of the protein even in the
absence of detergents. MG hydrolase assays veriﬁed that the soluble s-
Yju3p variant is still active against MGs in themmol/(hour*mg protein)
range (Fig. 1A).
3.2. The 3D structure of s-Yju3p
s-Yju3p crystallized in space group P212121. The structurewas deter-
mined using a combination of multi-wavelength anomalous dispersion
(MAD) and molecular replacement using the fragments obtained dur-
ing model building after MAD.We observe four molecules in the asym-
metric unit. The PISA server [45] suggests a tetramer to be stable, yet we
observed a peak corresponding to the size of monomeric protein in the
size exclusion chromatogram. The overall structure of s-Yju3p harbors
an α/β-hydrolase core and a cap containing four helices of different
lengths (Fig. 1B, C). The core harbors the active site with the catalytic
triad residues Ser123, Asp251 and His281 as proposed earlier based
on sequence homology [26]. The spatial arrangement of these residues
in our 3D structure conﬁrms that they form a catalytic triad. His281
and Asp251 are spatially arranged so they can form the charge transfer
relay involved in deprotonating Ser123 (Fig. 1D). Ser123 is in a position
to act as the nucleophile attacking the partially positively charged
carbonyl carbon of the substrate. Comparison with bMGL and hMGL
structures suggests that the oxyanion hole is formed by the main
chain amide groups of Met124 and Phe49. The cap is located around
the catalytic center in a position that could facilitate substrate binding
(Fig. 1B–D). In the N-terminal region of the cap, the short Helix 1
(Pro156–Asn161) and the longer Helix 2 (Thr164–Phe174) are just sep-
arated by Lys162 and Pro163, which induce a bent in the orientation of
the helix axes. The cap then crosses the molecule back and forth with
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posite end of the cap. Residues Arg179–Asp181 and Tyr209–Ser211
are arranged in an antiparallel manner and bring the forth and back
leg of the cap in spatial proximity (Fig. 1C). Arg264,which is a glutamine
in the native sequence, is positioned on a helix in the α/β-hydrolase
core with its side chain exposed to the aqueous environment and does
not show any side chain interaction with other residues. Residue 175,
which is a serine in s-Yju3p as opposed to a leucine in the native
enzyme, is located in the cap region in a loop near the end of Helix 2
(Fig. 1B). This spatial position corresponds nicely to the position of
Leu169Ser near the end of the ﬁrst helix in hMGL which served as tem-
plate for our solubility enhancement design. Three small holes were
observed in the surface of chain D, yet none of them seems big enough
to ﬁt the glycerol head group of an MG substrate or our MG-analog in
the presence of a p-nitrophenyl group.
3.3. s-Yju3p tetrahedral intermediate analog complex
Crystals diffracting to 2.2 Å were obtained from the co-
crystallization setup with a p-nitrophenyl ester of alkyl phosphonic
acid mimicking a C20:0 MG analog (Fig. 1E). The crystals were isomor-
phous to the crystals of the free form of s-Yju3p. Additional electron
density could be observed near the active site in chains A, B and D;Fig. 2.Conformational changes observed in the s-Yju3p cap.A, surface representation of the close
dark orange and the cap region in yellow, PDB code 4ZWN_C). B, surface representation of the s-
in orange, C20:0 MG analog as blue sticks, PDB code 4ZXF_C). C, superposition of helices 2 of
distance of 3.0 Å was measured between the C α-atoms of Gln165. D, close-up view of Ile166
and Met159 in the ligand bound form (PDB code 4ZXF_C). F, overlay of a transparent surface
analog (Ile166 and Met159 as sticks, the C20:0 MG analog as blue sticks).though it was not unambiguous enough to be interpreted as the C20:0
MG analog. In chain C however, we could observe electron density re-
sembling the shape of our ligand (Fig. 1F). In some regions of the ligand
carbon chain, the electron density was poorly deﬁned. This might be
caused by a low occupancy of the ligand (e.g. due to low water solubil-
ity) or by the ﬂexibility of the carbon chain. The substrate analog oxygen
that is equivalent to the carbonyl oxygen of the substrate is stabilized by
hydrogen bonds from the backbone nitrogen of the oxyanion-hole res-
idues Met124 and Phe49 (Fig. 1E, G). The substrate entrance channel
is mostly outlined by hydrophobic side chains (Leu151, Leu154,
Thr158, Met159, Lys162, Gln165 and Thr182 from the cap and Phe49,
Ile215, Phe218, Met219, and Ile253 from the core) (Fig. 1H, I). This hy-
drophobicity might be necessary to accommodate the hydrophobic car-
bon chain of theMG substrate in the binding pocket. Met159 and Ile166
of the cap line the outside of the entrance channel and form hydropho-
bic interactions with the carbon chain of the substrate analog partially
sticking out into the aqueous environment (Figs. 1H, I, 2) [46]. Unex-
pectedly, carbon-atoms C12 to C18 (corresponding to C14 to C20 in an
actual MG substrate) stick out of the hydrophobic substrate binding
channel between the cap and the core regions of the lipase (Fig. 2B).
This opening is quite distinct from the bMGL structures in the open con-
formation and from the substrate entrance tunnels observed in complex
structures of bMGL with different ligands [22,23,25]. The physiologicald conformation observed in chain C in standard orientation (α/β-hydrolase core colored in
Yju3p C20:0MG analog complex in standard orientation (α/β-hydrolase core in green, cap
s-Yju3p in the closed conformation (yellow) and in the ligand bound form (orange). The
and Met159 in the closed conformation (PDB code 4ZWN_C). E, close-up view of Ile166
representation and the cartoon representation of s-Yju3p in complex with the C20:0 MG
467P. Aschauer et al. / Biochimica et Biophysica Acta 1861 (2016) 462–470relevance of this wedge-like opening observed in presence of the cova-
lently bound ligand still needs to be established. Crystals of the free form
and the tetrahedral intermediate mimicking complex were isomor-
phous and the packing was identical. Therefore, we conclude that the
observed conformational changes are not caused by crystal contacts in
the cap region but represent an intrinsic conformational rearrangement.
3.4. Conformational ﬂexibility in the cap of s-Yju3p
Crystal structures of hMGL and bMGL revealed conformational ﬂex-
ibility of the cap region. The experimental structures of free s-Yju3p and
of the lipase in complex with the covalently bound inhibitor (Fig. 2A,
B) also pointed towards conformational ﬂexibility of the s-Yju3p cap.
Three of the four chains in the free form structure showed a closed sur-
facewith only one small hole in chain D (Fig. 2A). If this observed closed
cap conformation were to be rigid, such an enzyme could not be active
since it does not provide a possibility for the substrate to reach the ac-
tive site. Thus we hypothesized that additional cap conformations of s-
Yju3p have to exist. Indeed, slight conformational changes indicating
breathing movements of the lipase could be observed in one chain of
free s-Yju3p. The structure of s-Yju3p mimicking the tetrahedral reac-
tion intermediate in complex with the C20:0 MG substrate analog pro-
vided further proof forﬂexibility of the cap (Fig. 2B, C). In chainsA, B and
D, the cap region adopted the same conformation as in the free form
structure. In chain C conformational ﬂexibility could be observed espe-
cially in Helix 2 of the cap. Residues Thr164–Ile167 show marked
displacement of the Cα atoms compared to the position observed in
the free form (Cα-Cα distances of 2.8, 3.0, 2.4, and 2.9 Å, respectively)
while the rmsd value of the cap region encompassing residues
Pro156–Phe174 is 1.3 Å (Fig. 2C). In this region, a completely connected
electron-density for the protein chain of free s-Yju3p can be observed
which is clearly different in the s-Yju3p complex structure (Fig. S1).
Upon this conformational movement, the distance between the sideFig. 3. s-Yju3p molecular dynamics simulation. A, RMSF (root mean square ﬂuctuation) in Å a
dynamics simulation time, black shows the RMSD for the entire protein backbone, green show
for the backbone of the cap region. C-E: surface representation of s-Yju3p during MD-simulat
Yju3p α/β-hydrolase core and the cap are shown in light blue and beige, respectively. E, the acchains of Ile166 (located in Helix 2 of the cap) and Met159 (located in
Helix 1 of the cap) is increased from 3.9 Å to 7.4 Å (Fig. 2C–E). In the
complex structure, this hole is occupied by the carbon chain of the
C20:0 MG substrate analog (Fig. 2B, F). The published ligand bound
structures of hMGL do not contain a natural MG substrate or a substrate
analog. Nevertheless, the structure of hMGL in complexwith amolecule
termed ‘compound 1’ also showed conformational rearrangements of
the cap (PDB 3PE6, (24)). Different cap conformations were observed
for bMGL which appeared to arise from stochastic ﬂuctuations or en-
zyme breathing rather than being ligand induced [22,23,25].
In analogy, we assume stochastic ﬂuctuations in the cap of s-Yju3p
could facilitate entry of the substrate to the active site deeply buried
within the protein. In order to get ﬁrst clues on such a predicted open
conformation of s-Yju3p, four 100 ns molecular dynamics simulations
of the protein solvated in explicit water starting from the closed confor-
mation were carried out. In all four simulations, the cap region
(from residue Ile153 to Phe212) showed a signiﬁcantly higher ﬂexibility
than the protein core visible in the RMSF per residue plot (Fig. 3A).
In two simulation runs the protein stayed in a rather closed state,
whereas a signiﬁcant opening leading to an open conformation could
be observed in two different simulations. The overall back bone rmsd
reached a plateau around 2.0 Å, the rmsd for the α/β-hydrolase core
only stayed below 1.8 Å. The cap region however, reached a maximum
rmsd of 5.1 Å after approximately 22 ns, before the protein was again
morphing to a closed conformation (Fig. 3B). In contrast to an unfolding
of the cap region during the simulation, the observed increase and
subsequent decrease of the cap rmsd (relative to the equilibrated closed
conformation) is a strong indication for a directed cap movement from
the closed to the open state (and back). In this open state, the active site
entrance was visible and the active site Ser123 was accessible from the
solvent (Fig. 3C, D). It should be noted here, that the position of the
opening observed in theMD simulations is different to the one observed
in our crystal structure with the C20:0 MG substrate analog exiting thegainst amino acid residue. B, RMSD (root mean square deviation) in Å against molecular
s the RMSD only for the backbone of the α/β-hydrolase core, red shows the RMSD only
ion in standard view (C) and top-view (D) at 0 ns and after 25 ns in top view (E). The s-
tive site serine depicted in red is accessible in the open conformation.
Fig. 4. The general cap architecture is conserved among MGLs from different species. A, cap region of s-Yju3p C20:0 analog complex (PDB code 4ZXF); B, cap region of bMGL (PDB code
4KE8); C, cap region of hMGL (PDB code 3HJU). All panels are in top-view orientation.
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Fig. 5A, B). In conclusion, the MD simulations strongly suggest that
Yju3p is capable of showing an open conformation similar to the ones
in hMGL and bMGL.
3.5. Cavity shape and substrate binding versus substrate selectivity
Comparison of the cap regions of s-Yju3p and the other structurally
characterized MGLs (hMGL and bMGL) shows high conservation of theFig. 5. Substrate accessibilities and substrate speciﬁcities of MGLs from S. cerevisae, Ba
orientation. A–D, active site serines are marked with arrows, entrances are highlighted with
with the C20:0 substrate analog (cap region in orange and the α/β-hydrolase core in green); th
Yju3p resulting from the MD simulation (cap region in red and the α/β-hydrolase core in oran
(PDB code 3HJU, cap region in light blue and α/β-hydrolase core in blue). E–G, selectivity of di
left of the dashed line and unsaturated to the right. MG hydrolase activity assay with MG subs
binding pocket of s-Yju3p (C20:0 analog complex) (blue surface) with the bound C20:0 ligand
the bound C16:0 analog as yellow sticks. J, substrate binding pocket of hMGL (PDB code 4UUQ)overall S-shape of the cap region across different species. Despite
the differences in secondary structure elements, the overall course of
the protein backbones in these three different MGLs is very similar
(Fig. 4A–C) [12,21–24]. It could even be argued, that the interrupted
cap helix in Yju3p represents an evolutionary necessary functional
intermediate when comparing MGLs from Bacillus, S. cerevisae and
Homo sapiens. The introduction of the amphipathic cap helix apparently
changes the intracellular localization of the MGLs from a water-soluble,
cytosolic to a membrane- and LD-associated lipase. Consequently, thecillus sp. H-257, and Homo sapiens. Panels A–D and H–J are depicted in side-view
red circles, cavities inside the proteins are shown as gray surfaces. A, s-Yju3p in complex
e cavity is shown after removal of the ligand (PDB code 4ZXF). B, open conformation of s-
ge). C, bMGL (PDB code 4KE8, cap region in pink, α/β-hydrolase core in purple). D, hMGL
fferent MGLs for saturated and unsaturated MG substrates. Saturated substrates are to the
trates containing different fatty acids for Yju3p (E) bMGL (F), and hMGL (G). H, substrate
as blue sticks. I, substrate binding pocket (yellow surface) of bMGL (PDB code 4KE8) and
as green surface, the bound inhibitor SAR127303 is displayed in stick representation.
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ments became also possible.
s-Yju3p seems to have a substrate binding mode distinct from
bMGL and hMGL. In s-Yju3p, the carbon chain of the substrate analog
appears to be able to act as a wedge between the α/β-hydrolase core
and the cap region embedded by Leu166 and Met159 (Fig. 5A, red
circle). Thus, the end of the alkyl-chain in the complex structure of s-
Yju3p is observed below cap Helices 1 and 2. The path from the active
site serine to the opening of the binding pocket of hMGL and bMGL
follow a straight line and suggest positioning of the substrate above
the correspondinghelices (Fig. 5A–D). The transition-state intermediate
of s-Yju3pwas crystallized with a ligandmimicking a C20:0 alkyl chain.
One might assume that this conformation is linked to the preference of
this long aliphatic chain to be placed in a bent form in the hydrophobic
substrate binding pocket. A more direct, straight path would place larg-
er parts of the alkyl chain into the hydrophilic environment outside the
binding pocket. Interestingly, MD simulations also suggest a possible
open conformation with an opening between the ﬁrst stretch (Helices
1 and 2) and the second stretch (Helix 3) in the cap region. This is sim-
ilar to the open conformations experimentally observed in bMGL and
hMGL with the substrate entrance channel within the ﬁrst turn of the
S-shape within the cap region (Fig. 5C–D, red circles).
In this study, we also determined speciﬁc activities of Yju3p, hMGL
and bMGL with saturated and mono-unsaturated MGs of different
chain lengths. MG hydrolase activity assays showed that Yju3p activity
gradually decreased with increasing chain length using saturated MGs
as substrate. Actually,we could not detect activity using 18:0MGas sub-
strate (Fig. 5E). This trend was also observed using saturated MGs for
hMGL and bMGL (Fig. 5F, G), although these enzymes exhibited detect-
able activity against 18:0 MG. Onemight speculate that the ability to ﬁt
and enclose the alkyl chain within the binding pocket plays a role [22,
23]. Notably, Yju3p showed highest activity in the presence of monoun-
saturated MGs C16:1 and C18:1. The different shapes of the cavities
might also inﬂuence substrate speciﬁcities in different organisms
(Fig. 5H–J). The substrate preference of Yju3p nicely correlates to the
most abundant fatty acids within yeast [47]. This preference of Yju3p
for unsaturated long-chain fatty acids as substrates might be facilitated
by the bend observed in the Yju3p cavity (Fig. 5H). A saturated fatty
acid should also be able to form a bend in the carbon chain, yet the
preformed bend in an unsaturated fatty acid might preferably select
for accommodation of a long aliphatic chain inside the protein. hMGL
and bMGL exhibit highest activity using C12:0 as substrate. MGs with
short alkyl chain length are toxic to bacteria which can explain the ne-
cessity of bacterial MGL to be extremely efﬁcient in the turn-over of
these substrates. bMGL does not differentiate between C16:0 and
C16:1 but shows different activity for C18:0 and C18:1 MG substrates.
This might be explained by the fact that longer carbon chains need to
bend to be accommodated in the substrate binding pockets while a un-
saturated substrate is already pre-bent and easier to accommodate [22]
(Fig. 5H–J). hMGL shows less selectivity between C18:0 and C18:1 than
Yju3p and bMGL. This could be caused by the broad substrate entrance
channel of hMGL which applies less restriction on the rotamers of the
fatty acid moiety that could be ﬁtted inside the protein. It cannot be
ruled out completely, that the physico-chemical properties of the sub-
strates and concomitant different modes of substrate presentation in
the used aqueous micelle systems also inﬂuence themeasured absolute
activities in the assay.
Although the overall shape of the cap inMGLs seems to be conserved
across species, we could show that there are differences in the details of
the cap structures, substrate binding pockets, and in the substrate pref-
erence of Yju3p compared to hMGL and bMGL. While the structural
differences observed ﬁt the differences in substrate preference and pro-
vide a basis for their explanation, further biochemical data including en-
zyme kinetics, on- and off-rates, etc. are needed in order to get a clear
understanding of the mechanisms underlying the substrate selectivity
in MGLs.Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.bbalip.2016.02.005.
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